Regulatory management option analysis

Regulatory management option analysis

The assessment of regulatory needs list includes substances for which an assessment either is under development or has been completed. 

For each substance, the table shows the assessing authority (submitter), the concern, the status and the suggested follow-up action, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

Regulatory Management Option Analysis (RMOA) are assessments of regulatory needs. Publication of RMOA was initiated in February 2013 with the start of the implementation of the SVHC Roadmap. In 2019, authorities and in particular ECHA have moved to address more groups of substances.

The responsibility for the content of an assessment of regulatory needs rests with the authority that developed it. It is possible that other authorities do not have the same view and may develop a further assessment of regulatory needs for the same (group of) substances. Assessment of regulatory needs and their conclusions are compiled based on available information and may change in light of new information or further assessment.  

Last updated 15 July 2021. Database contains 264 unique substances/entries.
Filter the list
Date of intention:
Date of RMOA conclusion:
Latest update:

The List does not contain any Substances.
 
240-715-7
16669-59-3
Sweden
Carcinogenic
Mutagenic
Under development
Under development
No suggestion yet
08/04/2020
Details
222-871-8
3644-11-9
Sweden
Carcinogenic
Mutagenic
Under development
Under development
No suggestion yet
08/04/2020
Details
213-103-2
924-42-5
Sweden
Carcinogenic
Mutagenic
Under development
Under development
No suggestion yet
01/09/2020
Details
217-442-7
1852-16-0
Sweden
Carcinogenic
Mutagenic
Under development
Under development
No suggestion yet
08/04/2020
Details
679-769-5
2675-94-7
Sweden
Carcinogenic
Mutagenic
Under development
Under development
No suggestion yet
08/04/2020
Details
203-750-9
110-26-9
Sweden
Carcinogenic
Mutagenic
Under development
Under development
No suggestion yet
08/04/2020
Details
205-288-3
137-30-4
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
23/09/2014
Details
202-924-1
101-20-2
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Other
10/08/2018
Details
201-067-0
77-90-7
France
Endocrine disruption
Concluded
No need to initiate further regulatory risk management action at this time
None
07/11/2016
Details
201-071-2
77-94-1
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
22/01/2019
Details
260-830-6
57583-54-7
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Other
10/08/2018
Details
246-563-8
25013-16-5
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Restriction
17/01/2019
Details
202-830-0
100-21-0
France
Endocrine disruption
Concluded
No need to initiate further regulatory risk management action at this time
None
07/03/2017
Details
203-585-2
108-46-3
Finland
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
CLH
05/09/2019
Details
231-512-4
7601-90-3
Germany
Endocrine disruption
Under development
Under development
No suggestion yet
13/06/2016
Details
201-280-9
80-46-6
Germany
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
07/03/2017
Details
205-031-5
131-57-7
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
01/04/2015
Details
224-208-8
4247-02-3
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
19/01/2021
Details
201-545-9
84-61-7
Sweden
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
07/09/2015
Details
216-036-7
1478-61-1
Sweden
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
CLH
20/12/2018
Details
201-025-1
77-40-7
France
Endocrine disruption
Under development
Under development
No suggestion yet
07/03/2017
Details
205-029-4
131-56-6
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
23/09/2014
Details
205-028-9
131-55-5
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
23/09/2014
Details
239-139-9
15087-24-8
Germany
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
214-946-9
1222-05-5
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Other
28/01/2020
Details
690-137-8
5436-43-1
France
Endocrine disruption
Concluded
No need to initiate further regulatory risk management action at this time
Other
23/08/2019
Details
253-242-6
36861-47-9
Germany
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
253-242-6
36861-47-9
Denmark
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
26/05/2021
Details
show/hide
Cyclohexanone oxime EC / List no: 202-874-0 | CAS no: 100-64-1
Acetone oxime EC / List no: 204-820-1 | CAS no: 127-06-0
O,O',O''-(methylsilylidyne)trioxime 2-pentanone EC / List no: 484-460-1 | CAS no: -
2-Pentanone oxime EC / List no: 484-470-6 | CAS no: 623-40-5
2-Propanone, 2,2',2''-[O,O',O''-(ethylsilylidyne)trioxime] EC / List no: 611-631-1 | CAS no: 58190-57-1
2-Pentanone, O,O',O''-(ethenylsilylidyne)trioxime EC / List no: 700-810-0 | CAS no: 58190-62-8
2-Pentanone, 2,2',2''-[O,O',O''-(phenylsilylidyne)trioxime] EC / List no: 700-833-6 | CAS no: 1170315-90-8
pentan-2-one O,O',O'',O'''-silanetetrayltetraoxime EC / List no: 942-139-8 | CAS no: 1170315-92-0
Butan-2-one O,O',O''-(vinylsilylidyne)trioxime EC / List no: 218-747-8 | CAS no: 2224-33-1
Butan-2-one O,O',O''-(methylsilylidyne)trioxime EC / List no: 245-366-4 | CAS no: 22984-54-9
Butan-2-one O,O',O'',O'''-silanetetrayltetraoxime EC / List no: 251-882-0 | CAS no: 34206-40-1
Butanone oxime EC / List no: 202-496-6 | CAS no: 96-29-7
4-methylpentan-2-one oxime EC / List no: 203-298-2 | CAS no: 105-44-2
2-butanone-O,O',O''-(phenylsilylidyne)trioxime EC / List no: 433-360-6 | CAS no: 34036-80-1
-
-
Germany
Carcinogenic
Under development
Under development
No suggestion yet
02/06/2020
Details
207-069-8
431-03-8
Netherlands
Carcinogenic
Under development
Under development
No suggestion yet
09/11/2017
Details
215-133-1
1304-56-9
Netherlands
Carcinogenic
Under development
Under development
No suggestion yet
09/11/2017
Details
233-660-5
10294-40-3
Netherlands
Carcinogenic
Concluded
Appropriate to initiate regulatory risk management action
CLH
SVHC
08/07/2019
Details
202-681-1
98-56-6
Netherlands
Carcinogenic
Under development
Under development
No suggestion yet
09/11/2017
Details

Export search results to:

EU Privacy Disclaimer

This website uses cookies to ensure you get the best experience on our websites.